Home > PB Ratio > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
PB (Price/Book ) Ratio

The Current P/B Ratio of STRIDES PHARMA SCIENCE is 3.67.

Share Price ₹876.5Apr 26,2024
Market Cap ₹8,054.6 Cr
Book Value₹2,192.8 CrMar2023 - Consolidated Results
Price/Book 3.67xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of STRIDES PHARMA SCIENCE

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of STRIDES PHARMA SCIENCE is calculated as :

Current Market Cap [ ₹8,054.6 Cr] as on Apr 26,2024

(/) Book Value [ ₹2,192.8 Cr] based on Mar2023 - Consolidated Results

(=) P/B Ratio [ 3.67x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for STRIDES PHARMA SCIENCE , the investors are currently willing to pay '3.67 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of STRIDES PHARMA SCIENCE !

The chart below summarizes the trend in P/B Ratio of STRIDES PHARMA SCIENCE over the last five years.

Historical PB (Price/Book ) ratio chart of STRIDES PHARMA SCIENCE


PB Ratio Performance Analysis for STRIDES PHARMA SCIENCE

- STRIDES PHARMA SCIENCE 's latest p/b ratio is 3.67x.

- STRIDES PHARMA SCIENCE 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.60x.

- STRIDES PHARMA SCIENCE 's operated at median p/b ratio of 1.32x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, STRIDES PHARMA SCIENCE 's p/b ratio peaked in Mar2021 at 2.73x.

- STRIDES PHARMA SCIENCE 's p/b ratio hit its five-year low in Mar2020 of 1.15x.


How does STRIDES PHARMA SCIENCE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
STRIDES PHARMA SCIENCE 2,192.843.678,054.6
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.45360,920.0
CIPLA LTD23,346.004.87113,794.0
DR REDDYS LABORATORIES LTD23,140.404.51104,316.0
ZYDUS LIFESCIENCES LTD17,515.805.4595,380.9
DIVIS LABORATORIES LTD12,767.108.37106,860.0
MANKIND PHARMA LTD7,435.1612.7694,869.4
TORRENT PHARMACEUTICALS LTD6,198.0714.6991,057.0
LUPIN LTD12,315.605.9873,642.4
AUROBINDO PHARMA LTD26,839.802.4766,278.5
ABBOTT INDIA LTD3,146.0217.4754,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs STRIDES PHARMA SCIENCE 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.47x
Max industry PB 17.47x
Median industry PB 5.98x
Average industry PB 7.88x



You may also like the below Video Courses